17.11.2026
Advestra advises Novartis on Swiss law aspects of its USD 5.5 billion notes offering
Novartis has successfully placed notes in an aggregate principal amount of USD 5.5 billion. The notes were issued in four tranches: USD 500 million 4.90% notes due 2029, USD 1.5 billion 5.20% notes due 2032, USD 1.75 billion 5.30% notes due 2034 and USD 1.75 billion 5.50% notes due 2037. The notes were issued by Novartis Capital Corporation and are guaranteed by Novartis AG.
Advestra acted as Swiss legal counsel to Novartis. The team included Annette Weber, Thomas Reutter and Mariëlle von Nimwegen (all Capital Markets) as well as Céline Martin (Tax).